Boston Scientific Recalls HOT AXIOS Stent and Delivery System Over Deployment Failures
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
Boston Scientific has issued a Class I recall for 266 units of the HOT AXIOS Stent and Delivery System due to reports of deployment and expansion issues that may require surgical intervention.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on February 18, 2026 and geographically references Worldwide. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — FDA Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, MedicalDevices) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
Boston Scientific Corporation has initiated a voluntary recall of the HOT AXIOS Stent and Electrocautery-Enhanced Delivery System. The recall follows an increase in reports regarding stent deployment and expansion difficulties. According to the FDA, the most common foreseeable outcome is a prolongation of the medical procedure to exchange the faulty device for a new one. However, more serious cases where the first flange fails to deploy or expand can lead to a cascade of events requiring additional endoscopic or surgical intervention to remove the stent and close the puncture site.
Which Products Are Affected
The recall specifically involves the HOT AXIOS Stent and Electrocautery-Enhanced Delivery System (6mm x 8mm).
- Material Number (UPN): M00553520
- UDI-DI: 8714729904540
- Recall Number: Z-1161-2026
- Quantity: 266 units
- Lot Numbers: The recall affects over 200 specific lots, including 36067957, 36067958, 36067959, 36067960, 36067961, 36099410, 36102139, 36111317, 36111318, 36111319, and many others listed in the official FDA enforcement report.
The distribution of these devices is worldwide, including nationwide distribution in the United States and Puerto Rico, as well as over 50 other countries across Europe, Asia, the Middle East, and the Americas.
What You Should Do
This is a firm-initiated voluntary recall. Healthcare facilities and providers in possession of the affected lots should immediately stop using the devices and follow the instructions provided by Boston Scientific Corporation for the return or exchange of the product. For further inquiries, the recalling firm is located at 100 Boston Scientific Way, Marlborough, MA 01752.
Why This Matters
This recall has been designated as Class I, the most serious classification. Failure of the stent to deploy or expand correctly during a procedure can lead to significant medical complications, potentially requiring invasive surgery to repair puncture sites or remove the malfunctioning device.
Source
Information provided by the FDA.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.
What is this FDA recall about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more FDA Recalls updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category